Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in

Valladares Ayerbes, Manuel
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/3911
PMID: 25491381
ISSN: 0344-5704
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2015
Journal title
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Type of content
Artigo